🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Denmark / NCT05564130
Active, not recruiting Phase 4

Bicarbonate for In-Hospital Cardiac Arrest

NCT05564130 · tracked via the Priya Life Science Denmark tracker
Phase
Phase 4
Started
2023-02-06
Last updated
2026-02-17

Condition(s) studied

Cardiac Arrest

Investigational drug(s) / intervention(s)

Sodium bicarbonate →Sodium chloride

Sodium bicarbonate: Sodium bicarbonate 1 mmol/ml

Sodium chloride: Sodium chloride 9 mg/mL

Study summary

This is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of sodium bicarbonate during adult in-hospital cardiac arrest. There will be 22 enrolling sites in Denmark. 778 adult patients with in-hospital cardiac arrest receiving at least one dose of adrenaline will be enrolled. The primary outcome is return of spontaneous circulation and key secondary outcomes include survival at 30 days and survival at 30 days with a favorable neurological outcome.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. In-hospital cardiac arrest 2. Age ≥ 18 years 3. Received at least one dose of adrenaline during cardiopulmonary resuscitation (CPR) Exclusion Criteria: 1. Clearly documented "do-not-resuscitate" order prior to the cardiac arrest 2. Prior enrollment in the trial 3. Invasive mechanical circulatory support at the time of the cardiac arrest 4. Known or suspected pregnancy at the time of the cardiac arrest 5. Known objection by the patient to participate in the trial 6. Clinical indication for bicarbonate administration

Primary outcome measure(s)

Trial sites (22)

FacilityCityRegionStatus
Hospital of Southern Jutland - Aabenraa Aabenraa Denmark
Aalborg University Hospital Aalborg Denmark
Aarhus University Hospital Aarhus Denmark
Copenhagen University Hospital - Bispebjerg Bispebjerg Denmark
Copenhagen University Hospital - Rigshospitalet Copenhagen Denmark
Hospital of Southwest Jutland - Esbjerg Esbjerg Denmark
Copenhagen University Hospital - Gentofte Gentofte Municipality Denmark
Gødstrup Hospital Gødstrup Denmark
Copenhagen University Hospital - Herlev Herlev Denmark
North Denmark Region Hospital - Hjørring Hjørring Denmark
Holbæk Hospital Holbæk Denmark
Horsens Regional Hospital Horsens Denmark
Hvidovre Hospital Hvidovre Denmark
Kolding Hospital Kolding Denmark
Zealand University Hospital - Køge Køge Denmark
Nykøbing Falster Hospital Nykøbing Falster Denmark
Odense University Hospital Odense Denmark
Randers Regional Hospital Randers Denmark
Zealand University Hospital - Roskilde Roskilde Denmark
Slagelse Hospital Slagelse Denmark
Odense University Hospital - Svendborg Svendborg Denmark
Viborg Regional Hospital Viborg Denmark

More Lars Wiuff Andersen trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05564130 on ClinicalTrials.gov ↗ ← All trials in Denmark